Results 101 to 110 of about 1,888 (168)

Stress-induced IL-6 regulation in pediatric bone growth disorders: current insights and therapeutic strategies. [PDF]

Front Endocrinol (Lausanne)
Sohail Z, Hadi NBA, Rehman A, Asghar M, Zaman F.   +4 more
europepmc   +1 more source

Synergistic Enhancement of Oxygen Permeability in Silane-Modified Hydrogel Networks for Advanced Ophthalmic Applications. [PDF]

Gels
Lee MJ, Sung AY.
europepmc   +1 more source

A Robust and Universal LC-MS/MS Method for Determination of N-Nitrosodimethylamine in Pharmaceuticals Using a C30 Column. [PDF]

J Sep Sci
An B, Kim U, Seo S, Kim J, Jeong C, Jeong W, Ko E, Kim J, Cho HD, Han SB.   +9 more
europepmc   +1 more source

Research progress in molecular targeted therapy for inflammatory bowel disease. [PDF]

J Transl Med
Liu N, Pan C, Qu L.
europepmc   +1 more source

Differentiating the in vitro toxicity of solid-surface composite dust: A comparison of material components and abrasive particles. [PDF]

Toxicol Lett
Mandler WK, McKinney W, Qi C, Knepp A, Lee EG, Kang S, Keeley S, Qian Y.   +7 more
europepmc   +1 more source

Favorable coronary outcomes following IL-6 blockade with tocilizumab in IVIG-resistant kawasaki disease: a case series. [PDF]

Front Immunol
Zheng J, Xu Y, Pu Y, Liu J, Cao Z, Wang Y.   +5 more
europepmc   +1 more source

Mogamulizumab for adult T-cell leukemia/lymphoma: a literature review. [PDF]

Transl Cancer Res
Jones C, Wang JC, Saeed H.
europepmc   +1 more source

Exercise-modulated IL-6 in cancer cachexia: molecular mechanisms and therapeutic potential. [PDF]

J Transl Med
Wei S, Lv X, Xu Y, Ding S.
europepmc   +1 more source

Extracellular vesicle-based therapies for neurodegenerative diseases. [PDF]

NeuroImmune Pharm Ther
Hu G, Gogzheyan C, Panja S, Sil S, Gendelman HE.   +4 more
europepmc   +1 more source